Scripps Research Logo

News Release


WHAT: A special panel, Stopping the Deadly Ebola Outbreak: The San Diego Connection in Saving Lives and Providing Hope, will feature local scientists, drug developers and humanitarian assistance workers at the forefront of efforts to stop the deadly Ebola virus outbreak in West Africa. The panel is free and open to members of the public, the media and the local research community.

WHEN: Wednesday, August 27. 4:00—6:00 pm

WHO: The panel will feature three speakers:

  • Erica Ollmann Saphire – Professor, The Scripps Research Institute. Dr. Saphire heads an international collaborative effort to find antibodies to fight Ebola virus, including the experimental serum called ZMapp, which may have saved the lives of two American aid workers.
  • Mark O'Donnell – Chief Operating Officer, PCI (Project Concern International). Mr. O'Donnell oversees the implementation of PCI's country programs in Africa, Asia and the Americas. His organization is involved in humanitarian assistance efforts in Liberia to prevent the spread of Ebola, train health workers and deliver emergency medical supplies.
  • Kevin Whaley – Chief Executive Officer, Mapp Biopharmaceutical. Dr. Whaley leads the drug development company that produced the experimental ZMapp treatment. He co-founded Mapp to develop antibody-based MPTs, therapeutics and mucosal vaccines that are appropriate for large, cost-sensitive, global health markets.

WHERE: The panel will be held in the atrium of the Beckman Building at The Scripps Research Institute (TSRI), 10650 North Torrey Pines Road, La Jolla, California 92037. For maps and information on parking, go to:

RSVP: Reservations are required. Please RSVP to Chelsea Luedeke, (858) 784-7083 or

About Project Concern International

PCI provides humanitarian assistance to people affected by disasters and complex emergencies; helps governments, local organizations, and communities better manage risk and respond to emergencies when they arise; and integrates efforts to help reduce vulnerability to disasters into all of its ongoing programs.

About The Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI announced a strategic affiliation with the California Institute for Biomedical Research (Calibr), representing a renewed commitment to the discovery and development of new medicines to address unmet medical needs. For more information, see

# # #

For information:
Office of Communications
Tel: 858-784-2666
Fax: 858-784-8118